Kodak gets FDA OK for new PACS tools for non-invasive cardiac tests
Eastman Kodak Company today announced that it has received FDA clearance for several specialized tools for diagnosing non-invasive cardiac scans. These specialized functions — cardiac review and analysis; cardiac cage removal in 3D imaging and cardiac calcium scoring — are being integrated into the next version of KODAK CARESTREAM PACS software and for commercial release in mid-2006.
The cardiac review and analysis tools provide four-chamber and cross-sectional views of the heart and panoramic and cross-sectional views of cardiac vessels. The system also analyzes calcified plaque in five main blood vessels of the heart, and enables radiologists to visually remove anatomy around the heart not required for cardiac viewing.
Kodak also received FDA clearance for bone removal and vessel analysis enhancements that are used with CT exams of arteries and veins throughout the body.
Each of these components are part of Kodak's real-time 3D capabilities that also include MIP (maximum intensity projection), MinIP (minimum intensity projection), MPR (multiplanar reconstruction), volume rendering, tissue definition, and vessel tracking functionality, the company said.
The cardiac review and analysis tools provide four-chamber and cross-sectional views of the heart and panoramic and cross-sectional views of cardiac vessels. The system also analyzes calcified plaque in five main blood vessels of the heart, and enables radiologists to visually remove anatomy around the heart not required for cardiac viewing.
Kodak also received FDA clearance for bone removal and vessel analysis enhancements that are used with CT exams of arteries and veins throughout the body.
Each of these components are part of Kodak's real-time 3D capabilities that also include MIP (maximum intensity projection), MinIP (minimum intensity projection), MPR (multiplanar reconstruction), volume rendering, tissue definition, and vessel tracking functionality, the company said.